You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
Healthcare providers need multiplexed tests that can differentiate the flu from the coronavirus so they can treat patients quickly and appropriately.
The RT-PCR test runs on the Cobas 6800/8800 Systems and had previously received breakthrough device designation from the FDA.
The panel also said that if any nation does decide to allow germline genome editing, its use should be limited to preventing serious monogenic diseases.
The New York Times reports the US plans to redirect funds it owes in dues to the World Health Organization to other health-related programs at the United Nations.
The US has declined to join a global SARS-CoV-2 vaccine effort, the Washington Post reports.
The head of the World Health Organization urges nations to join a global vaccine agreement, according to NPR.
The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.
The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.
About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.
In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.